Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 49.12M | $62.0M | -- | +1.80M | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 42.81M | $54.0M | -- | -20.96M | 2026-06-30 |
| Soleus Capital Management, L.P. | 42.81M | $54.0M | -- | +1.30M | 2026-06-30 |
| STATE STREET CORP | 35.86M | $45.0M | -- | +5.36M | 2026-06-30 |
| CITADEL ADVISORS LLC | 29.55M | $37.0M | -- | +7.44M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 27.25M | $34.0M | -- | +581.2K | 2026-06-30 |
| Clearbridge Investments, LLC | 19.65M | $25.0M | -- | +28.5K | 2026-06-30 |
| Eversept Partners, LP | 18.72M | $23.0M | -- | -117.5K | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 16.63M | $21.0M | -- | +5.46M | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 14.56M | $18.0M | -- | +885.2K | 2026-06-30 |
